Analysts expect Amneal Pharmaceuticals, Inc. to report revenue of 888.45 M for Q4 26, against a range of 854.55 M to 922.36 M. The most recent reported quarter, Q3 26, came in at 862.68 M, a 9.0% beat against the 791.16 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 730.52 M | 695.42 M | 724.51 M | 784.51 M | 814.32 M | 722.52 M | 796.20 M | 862.68 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 771.05 M | 748.93 M | 740.55 M | 780.09 M | 807.79 M | 710.18 M | 876.78 M | 841.89 M | 922.36 M | 915.28 M | 876.48 M | 905.17 M | 1.00 B | 912.55 M | 1.03 B | 1.01 B | |||||||||
| Low Estimate | 725.76 M | 626.76 M | 670.00 M | 728.83 M | 723.73 M | 659.86 M | 753.42 M | 740.42 M | 854.55 M | 789.63 M | 722.19 M | 771.87 M | 910.89 M | 783.46 M | 951.96 M | 926.92 M | |||||||||
| Consensus Estimate | 748.41 M | 687.84 M | 705.27 M | 754.46 M | 765.76 M | 685.02 M | 815.10 M | 791.16 M | 888.45 M | 852.45 M | 799.34 M | 838.52 M | 955.45 M | 848.01 M | 992.35 M | 970.53 M |
Analysts expect Amneal Pharmaceuticals, Inc. to report earnings per share of 0.23 for Q4 26, against a range of 0.21 to 0.25. The most recent reported quarter, Q3 26, came in at 0.26, a 13.0% beat against the 0.23 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.12 | 0.21 | 0.25 | 0.17 | 0.21 | 0.27 | 0.30 | 0.26 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 0.17 | 0.15 | 0.18 | 0.15 | 0.20 | 0.17 | 0.25 | 0.25 | 0.25 | 0.28 | 0.32 | 0.36 | 0.36 | 0.34 | 0.40 | 0.42 | |||||||||
| Low Estimate | 0.15 | 0.13 | 0.16 | 0.13 | 0.18 | 0.15 | 0.21 | 0.21 | 0.21 | 0.26 | 0.30 | 0.30 | 0.32 | 0.30 | 0.34 | 0.34 | |||||||||
| Consensus Estimate | 0.16 | 0.14 | 0.17 | 0.14 | 0.19 | 0.16 | 0.23 | 0.23 | 0.23 | 0.27 | 0.31 | 0.33 | 0.34 | 0.32 | 0.37 | 0.38 |
Pull Wall Street consensus for Amneal Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=AMRX&mode=revenue&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "AMRX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/estimates?ticker=AMRX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();